Skip to content

LightMood Intervention to reduce depression symptoms in obese adults: A randomized-controlled online intervention study

LightMood Intervention to reduce depression symptoms in obese adults: A randomized-controlled online intervention study - LightMood

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00029219
Enrollment
128
Registered
2023-05-19
Start date
2025-09-08
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obese adults with depressive symptoms

Interventions

Group 1: LightMood online intervention to reduce depression symptoms. Trial duration for participants comprises 7 months (including 4 months interventions, 1-month follow-up period and 3-month follo
The intervention will be compared to standard care. Participants in the control group will have access to the conventional healthcare available in Germany, and their access to other therapeutic and/or

Sponsors

LVR-Universitätsklinik Essen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: -Patients with a BMI = 30 -Depressive symptoms (PHQ-8 = 10) -Adequate digital literacy -Internet-enabled device -Informed consent

Exclusion criteria

Exclusion criteria: -Bariatric surgery within the past year or planned within the next 6 months -Weekly individual psychotherapy -No private Internet access -Regulation of a new psychopharmacists within the last 2 weeks

Design outcomes

Primary

MeasureTime frame
Depression symptoms (CESD-R) (T0, T1, T2, T3)

Secondary

MeasureTime frame
-Improvement in self-efficacy (GSES), quality of life (WHOQOL) and mindfulness (FFA) -Reduction of eating disorder-specific symptoms (EDE-2-B; EDI-2; EDE-Q8) -Reduction of Body Mass Index (BMI) -Progress/development of depressive symptoms and other sec. outcomes about the measurement time points (PHQ-4; Distress) (Measure: During Treatment) - satisfaction with treatment; and usability of the LightMood intervention -Usage behaviour -Predictors of usage behaviour The measuring times of the measuring instruments mentioned above take place at T0, T1, T2 and T3.

Countries

Germany

Contacts

Public ContactMartin Teufel

LVR-Universitätsklinik Essen

Psychosomatik.Essen@lvr.de+49 7227 500

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 6, 2026